Zehn Jahre Erfahrung mit extra-korporaler Membranoxygenierung (ECMO)

G. Mols; T. Loop; G. Hermle; J. Buttler; B. Huber; J. Schubert; A. Benzing

doi:10.1055/s-2001-10241

AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, Table of Contents

Anästhesiol Intensivmed Notfallmed Schmerzther 2001; 36(1): 4-14
DOI: 10.1055/s-2001-10241

ÜBERSICHT

ORIGINALARBEIT
© Georg Thieme Verlag Stuttgart · New York

Zehn Jahre Erfahrung mit extra-korporaler Membranoxygenierung (ECMO)[1]

G. Mols¹ T. Loop¹ G. Hermle¹ J. Buttler¹ B. Huber¹ J. Schubert² A. Benzing¹

¹Anaesthesiologische Universitätsklinik Freiburg
²Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universität Rostock

Abstract

Zusammenfassung.

Hintergrund: Extrakorporale Membranoxygenierung (Extracorporeal Membrane Oxygenation: ECMO) ist eine supportive Behandlung für das schwere Lungenversagen. Wir beschreiben unsere Behandlungsergebnisse bei 245 Patienten mit schwerem ARDS (Acute Respiratory Distress Syndrome), von denen 62 mit der ECMO behandelt wurden. Methodik: Die Daten aller ARDS-Patienten wurden zwischen 1991 und 1999 prospektiv erfasst. Neben der Überlebensrate wurden mehrere klinische Parameter sowohl bei den mit ECMO als auch bei den konventionell behandelten Patienten aufgeführt und evaluiert. Ergebnisse: 138 Patienten wurden uns aus auswärtigen Kliniken zugewiesen, 107 Patienten stammten aus Freiburg, z. T. von anderen hausinternen Intensivstationen. Von den mit ECMO behandelten Patienten überlebten 55 %. ECMO war mit sehr wenigen Komplikationen verbunden (eine davon tödlich). Kein Parameter, der zu Beginn oder während der ECMO-Behandlung erhoben wurde, erlaubte die Vorhersage der individuellen Prognose. Von den konventionell behandelten Patienten, bei denen der pulmonale Gasaustausch weniger stark eingeschränkt war, überlebten 61 %. Schlussfolgerung: ECMO ist eine wichtige Behandlungsoption bei schwerem ARDS. Allerdings wurde eine dadurch erreichbare höhere Überlebensrate bislang in keiner randomisierten kontrollierten Studie nachgewiesen. Bis zur Entwicklung einer kausalen oder in anderer Hinsicht überlegenen Therapie sollte ECMO bei ausgewählten Patienten eingesetzt werden.

Ten Years of Experience in Extracorporeal Membrane Oxygenation.

Objective: Extracorporeal membrane oxygenation (ECMO) is a supportive therapy used for severe acute respiratory distress syndrome (ARDS). We present outcome, clinical parameters, and complications in a cohort of 245 ARDS patients of whom 62 were treated with ECMO. Methods: Data of all ARDS patients were prospectively collected between 1991 and 1999. Outcome and clinical parameters of patients treated with and without ECMO were evaluated. Results: Hundred-thirty-eight patients were referred from other hospitals, 107 were primarily located in our hospital. About one fourth of these patients was treated with ECMO. The survival rate was 55 % in ECMO patients and 61 % in non-ECMO patients. ECMO resulted in very few complications, one of them was fatal. No parameter before or during ECMO could be used to predict the individual prognosis. Conclusion: ECMO is a therapeutic option for patients with severe ARDS, likely to increase survival. However, a randomized controlled study proving its benefit is still awaited. Until the development of a causal or otherwise superior therapy ECMO should be used in selected patients.

Schlüsselwörter:

ECMO - ARDS - ALI

Key words:

ECMO - ARDS - ALI

Full Text

References

Literatur

1 Hill J D, O’Brien T G, Murray J J, Dontigny L, Bramson M L, Osborn J J, Gerbode F. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock lung syndrome). Use of the Bramson membrane lung. New England Journal of Medicine. 1972; 286 629-634
2 Zapol W, Snider M, Hill J, Fallat R, Bartlett R, Edmunds L, Morris A, Peirce E, Thomas A, Roctor P, Drinker P, Pratt P, Bagniewski A, Miller R. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. Journal of the American Medical Association. 1979; 242 2193-2196
3 Gattinoni L, Kolobow T, Tomlinson T, Iapichino G, Samaja M, White D, Pierce J. Low-frequency positive pressure ventilation with extracorporeal carbon dioxide removal (LFPPV-ECCO₂R): an experimental study. Anesthesia Analgesia. 1978; 57 470-477
4 Kolobow T, Gattinoni L, Tomlinson T, Pierce J E. An alternative to breathing. Journal of Thoracic and Cardiovascular Surgery. 1978; 75 261-266
5 Gattinoni L, Pesenti A, Rossi G P, Vesconi S, Fox U, Kolobow T, Agostini A, Pelizzola A, Langer M, Uziel L, Longoni F, Damia G. Treatment of acute respiratory failure with low-frequency positive pressure ventilation and extracorporeal removal of CO₂. The Lancet August/1980: 292-294
6 Hickling K G, Henderson S J, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Medicine. 1990; 16 372-377
7 Briegel J, Hummel T, Lenhart A, Heyduck M, Schelling G, Haller M. Complications during long-term extracorporeal lung assist (ECLA). Acta Anaesthesiologica Scandinavica. 1996; Suppl. 109 121-122
8 Tajimi K, Kasai T, Nakatani T, Kobayashi K. Extracorporeal lung assisit for patient with hypercapnia due to status asthmaticus. Intensive Care Medicine. 1988; 14 588-589
9 Müller E. Pro: Hat ECMO eine Zukunft?. Anästhesiologie, Intensivmedizin, Notfallmedizin & Schmerztherapie. 1997; 32 635-637
10 Sydow M. Kontra: Hat die extrakorporale Membranoxygenierung (ECMO) eine Zukunft?. Anästhesiologie, Intensivmedizin, Notfallmedizin & Schmerztherapie. 1997; 32 632-634
11 Bernard G R, Artigas A, Brigham K L, Carlet J, Falke K, Hudson L, Lamy M, Legall J R, Morris A, Spragg R. and the Consensus Committee . Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Medicine. 1994; 20 225-232
12 Mols G, Brandes I, Kessler V, Lichtwarck-Aschoff M, Loop T, Geiger K, Guttmann J. Volume-dependent compliance in ARDS: proposal of a new diagnostic concept. Intensive Care Medicine. 1999; 25 1084-1091
13 Pelosi P, Tubiolo D, Mascheroni D, Vicardi P, Crotti S, Valenza F, Gattinoni L. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. American Journal of Respiratory and Critical Care Medicine. 1998; 157 387-393
14 Rossaint R, Falke K J, Lopez F, Slama K, Pison U, Zapol W M. Inhaled nitric oxide for the adult respiratory distress syndrome. New England Journal of Medicine. 1993; 328 399-405
15 Benzing A, Mols G, Brieschal T, Geiger K. Hypoxic pulmonary vasoconstriction in non-ventilated lung areas contributes to differences in hemodynamic and gas exchange responses to inhalation of nitric oxide. Anesthesiology. 1997; 86 1254-1261
16 Benzing A, Mols G, Guttmann J, Kaltofen H, Geiger K. Effect of different doses of inhaled nitric oxide on pulmonary capillary pressure and on longitudinal distribution of pulmonary vascular resistance in ARDS. British Journal of Anaesthesia. 1998; 80 440-446
17 Pranikoff T, Hirschl R B, Steimle C N, H L Anderson I II, Bartlett R H. Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Critical Care Medicine. 1997; 25 28-32
18 Michaels A J, Schriener R J, Kolla S, Awad S S, Rich P B, Reickert C, Younger J, Hirschl R B, Bartlett R H. Extracorporeal life support in pulmonary failure after trauma. Journal of Trauma. 1999; 46 638-645
19 Morris A H, Wallace C J, Melove R L, Clemmer T P, et a l. et al . Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine. 1994; 149 295-305
20 Zwischenberger J B, Conrad S A, Alpard S K, Grier L R, Bidani A. Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure. Annals of Thoracic Surgery. 1999; 68 181-187
21 Pranikoff T, Hirschl R B, Remenapp R, Swaniker F, Bartlett R H. Venovenous extracorporeal life support via percutaneous cannulation in 94 patients. Chest. 1999; 115 818-822
22 Hickling K G. The pressure-volume curve is greatly modified by recruitment: a mathematical model of ARDS lungs. American Journal of Respiratory and Critical Care Medicine. 1998; 158 194-202
23 Jonson B, Svantesson C. Elastic pressure-volume curves: what information do they convey?. Thorax. 1999; 54 82-87
24 Jonson B, Richard J -C, Straus C, Mancebo J, Lemaire F, Brochard L. Pressure-volume curves and compliance in acute lung injury: evidence of recruitment above the lower inflection point. American Journal of Respiratory and Critical Care Medicine. 1999; 159 1172-1178
25 Amato M BP, Barbas C SV, Medeiros D M, Magaldi R B, Schettino G PP, Filho G L, Kairalla R A, Deheinzelin D, Munoz C, Oliveira R, Takagaki T V, Carvalho C RR. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. New England Journal of Medicine. 1998; 338 347-354
26 Frey D E. Multiple system organ failure. St. Louis. Mosby Year Book Inc 1992: 3-14
27 Murray J F, Matthay M A, Luce J M, Flick M R. An expanded definition of the adult respiratory distress syndrome. American Review of Respiratory Disease. 1988; 138 720-723
28 Kolla S, Awad S S, Rich P B, Schreiner R J, Hirschl R B, Bartlett R H. Extracorporeal life support for 100 adult patients with severe respiratory failure. Annals of Surgery. 1997; 226 544-564
29 Lennartz H. Extracorporeal lung assist in ARDS: history and state of the art. Acta Anaesthesiologica Scandinavica. 1996; Suppl. 109 114-116
30 Knoch M, Kukule I, Müller E, Höltermann W. Lungenfunktion ein Jahr nach extrakorporalem Lungenersatz (ELA): Langzeitverlauf von Patienten mit schwerstem ARDS. Anästhesiologie, Intensivmedizin, Notfallmedizin & Schmerztherapie. 1992; 27 477-482
31 Schelling G, Stoll C, Haller M, Briegel J, Manert W, Hummel T, Lenhart A, Heyduck M, Polasek J, Meier M, Preuß U, Bullinger M, Schüffel W, Peter K. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Critical Care Medicine. 1998; 26 651-659
32 Schelling G, Stoll C, Vogelmeier C, Hummel T, Behr J, Kapfhammer H -P, Rothenhäusler H -B, Haller M, Durst K, Krauseneck T, Briegel J. Pulmonary function and health-related quality of life in a sample of long-term survivors of the acute respiratory distress syndrome. Intensive Care Medicine. 2000; 26 1304-1311
33 Lewandowski K, Rossaint R, Pappert D, Gerlach H, Slama K J, Weidemann H, Frey D JM, Hoffmann O, Keske U, Falke K J. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Medicine. 1997; 23 819-835
34 Gattinoni L, Pesenti A, Mascheroni D, Marcolin R, Fumagalli R, Rossi F, Iapichino G, Romagnoli G, Uziel L, Agostini A, Kolobow T, Damia G. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. Journal of the American Medical Association. 1986; 256 881-887
35 Egan T M, Duffin J D, Glynn M FX, Todd R RJ, DeMajo W, Murphy E, Fox L, Cooper J D. Ten-year experience with extracorporeal membrane oxygenation for severe respiratory failure. Chest. 1988; 94 681-687
36 Bindslev L, Eklund J, Norlander O, Swedenborg J, Olsson P, Nilsson E, Larm O, Gouda I, Malmberg A, Scholander E. Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung. Anesthesiology. 1987; 67 117-120
37 Bindslev L, Böhm C, Jolin A, Jonzon K, Olsson P, Ryniak S. Extracorporeal carbon dioxide removal performed with surface-heparinized equipment in patients with ARDS. Acta Anaesthesiologica Scandinavica. 1991; 35 1991 125-131
38 Peters J, Radermacher P, Kuntz M E, Rosenbauer K A, Breulmann M, Bürrig K F, Hopf H B, Rossaint R, Schulte H D, Olsson P, Falke K J. Extracorporeal CO2-removal with a heparin coated artificial lung. Intensive Care Medicine. 1988; 14 578-584
39 Fjalldall O, Torfason B, Önundarson P T, Thorseinsson A, Vigfusson G, Stefansson T, Magnusson V. Prolonged total extracorporeal lung assistance without systemic heparinization. Acta Anaesthesiologica Scandinavica. 1993; 37 115-120
40 Pesenti A, Gattinoni L, Bombino M. Long term extracorporeal respiratory support: 20 years of progress. Intensive & Critical Care Digest. 1993; 12 15-18
41 Rossaint R, Pappert D, Gerlach H, Lewandowski K, Keh K, Falke K. Extracorporeal membrane oxygenation for transport of hypoxaemic patients with severe ARDS. British Journal of Anaesthesia. 1997; 78 241-246
42 Kee S S, Sedgwick J, Bristow A. Interhospital transfer of a patient undergoing extracorporeal carbon dioxide removal. British Journal of Anaesthesia. 1991; 66 141-144
43 Rich P B, Awad S S, Kolla S, Annich G, Schreiner R J, Hirschl R B, Bartlett R H. An approach to the treatment of severe adult respiratory failure. Journal of Critical Care. 1998; 13 26-36
44 Kolobow T, Scola M, Gattinoni L, Pesenti A. Adult respiratory distress syndrome (ARDS): why did ECMO fail?. The International Journal of Artificial Organs. 1981; 4 58-59
45 Hensel M, Kox W. Increased intrapulmonary oxygen consumption in mechanically ventilated patients with pneumonia. American Journal of Respiratory and Critical Care Medicine. 1999; 160 137-143
46 Habashi N M, Reynolds H N, Borg U, Cowley R A. Letter. American Journal of Respiratory and Critical Care Medicine. 1995; 151 255-256
47 Muscedere J G, Mullen J BM, Gan K, Slutsky A S. Tidal ventilation at low airway pressures can augment lung injury. American Journal of Respiratory and Critical Care Medicine. 1994; 149 1327-1334
48 Keszler M, Subramantiam K NS, Smith Y A, Dhanireddy R, Mehta N, Molina B, Cox C B, Moront M G. Pulmonary management during extracorporeal membrane oxygenation. Critical Care Medicine. 1989; 17 495-500
49 UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. The Lancet 1996 348: 75-82
50 Roberts T E. and the Extracorporeal Membrane Oxygenation Economics Working Group on behalf of the Extracorporeal Membrane Oxygenation Trial Steering Group . Economic evaluation and randomised controlled trial of extracorporeal membrane oxygenation: UK collaborative trial. British Medical Journal. 1998; 317 911-915
51 Hickling K G. Extracorporeal CO₂ removal in severe adult respiratory distress syndrome. Anaesthesia and Intensive Care. 1986; 14 46-53
52 Donahoe M, Rogers R M. An anecdote is an anecdote is an anecdote ... but clinical trial is data. American Journal of Respiratory and Critical Care Medicine. 1994; 149 293-294
53 The Acute Respiratory Distress Syndrome Network:. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New England Journal of Medicine 2000 342: 1301-1308
54 Abrams J H, Gilmour I J, Kriett J M, Bitterman P B, Irmiter R J, McComb R C, Cerra F B. Low-frequency positive-pressure ventilation with extracorporeal carbon dioxide removal. Critical Care Medicine. 1990; 18 218-220
55 Terasaki H, Higashi K, Takeshita J, Tanoue T, Morioka T. Resuscitation by extracorporeal lung assist of a patient suffocating after inhalation of sawdust particles. Critical Care Medicine. 1990; 18 239-240
56 Pesenti A, Rossi G P, Pelosi P, Brazzi L, Gattinoni L. Percutaneous extracorporeal CO₂ removal in a patient with bullous emphysema with recurrent bilateral pneumothoraces and respiratory failure. Anesthesiology. 1990; 72 571-573
57 Gillet D S, Gunning K EJ, Sawicka E H, Bellingham A J, Ware R J. Life threatening sickle chest syndrome treated with extracorporeal membrane oxygenation. British Medical Journal. 1987; 294 81-82
58 Lee W A, Kolla S, Schreiner RJ J r., Hirschl R B, Bartlett R H. Prolonged extracorporeal life support (ECLS) for varicella pneumonia. Critical Care Medicine. 1997; 25 977-982
59 Mols G, Benzing A, Loop T. Behandlung eines schweren, durch Leptospirose verursachten akuten Lungenversagens (ARDS) mit der extrakorporalen Lungenunterstützung (ECLA) - ein Fallbericht. Intensivmedizin. 1995; 32 225-228
60 Müller E, Knoch M, Höltermann W, Lennartz H. ARDS bei Legionellen-Pneumonie - erfolgreiche Behandlung mit dem extrakorporalen CO₂-Eliminationsverfahren. Anästhesiologie, Intensivmedizin, Notfallmedizin & Schmerztherapie. 1989; 24 177-180
61 Dorrington K, McRae K, Gardaz J, Dunnill M, Sykes M, Wilkinson A. A randomized comparison of total extracorporeal CO₂ removal with conventional mechanical ventilation in experimental hyaline membrane disease. Intensive Care Medicine. 1989; 15 184-191
62 Borelli M, Kolobow T, Spatola R, Prato P, Tsuno K. Severe acute respiratory failure managed with continuous positive airway pressure and partial extracoporeal carbon dioxide removal by an artificial membrane lung: A controlled, randomized animal study. American Review of Respiratory Disease. 1988; 138 1480-1487
63 Dreyfuss D,Saumon G. Barotrauma is volutrauma, but which volume is the one responsible?. Intensive Care Medicine. 1992; 18 139-141
64 Brunet F, Mira J -P, Belghith M, Monchi M, Renaud B, Fierobe L, I H amy, Dhainaut J -F, Dall’ava-Santucci J. Extracorporeal carbon dioxide removal technique improves oxygenation without causing overinflation. American Journal of Respiratory and Critical Care Medicine. 1994; 149 1557-1562

1 Diese Arbeit ist Herrn Prof. Dr. Klaus Geiger zum 60. Geburtstag gewidmet. Teile dieses Manuskripts wurden publiziert in: The American Journal of Surgery 2000; 180: 144-154. Mols et al.: Extracorporeal Membrane Oxygenation (ECMO) - A Ten-Year Experience. Abdruck in überarbeiteter Form mit Genehmigung durch Excerpta Medica Inc.

Dr. G. Mols

Anaesthesiologische Universitätsklinik Freiburg

Hugstetterstr. 55

79106 Freiburg

Email: mols@ana1.ukl.uni-freiburg.de